
As of 30-JUN-2026, promoters held 75.26% of Akums Drugs and Pharmaceuticals (0.00 pp from 31-MAR-2026), foreign institutional investors 1.91%, domestic institutions 13.44% and the public 6.66%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Promoters held 75.26% of Akums Drugs and Pharmaceuticals as of 30-JUN-2026, unchanged from 75.26% in 31-MAR-2026.
Foreign institutional investors held 1.91% of Akums Drugs and Pharmaceuticals as of 30-JUN-2026, a change of +0.54 pp from the previous quarter.
Domestic institutional investors, including mutual funds and insurers, held 13.44% of Akums Drugs and Pharmaceuticals as of 30-JUN-2026 (-0.91 pp from the previous quarter).
As of 30-JUN-2026, Akums Drugs and Pharmaceuticals' shareholders were promoters (75.26%), foreign institutional investors 1.91%, domestic institutions 13.44% and the public 6.66%, as filed with the stock exchanges.
Track AKUMS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.